New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
11:51 EDTCMG, AZN, ISRG, SNDK, AKAMOptions with increasing implied volatility: AKAM ISRG CMG SNDK AZN
News For AKAM;ISRG;CMG;SNDK;AZN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 19, 2015
07:48 EDTAKAMAkamai downgraded on valuation, comps at Oppenheimer
Subscribe for More Information
07:25 EDTAKAMAkamai price target raised to $88 from $79 at UBS
Subscribe for More Information
06:38 EDTAKAMAkamai downgraded to Perform from Outperform at Oppenheimer
May 18, 2015
10:02 EDTSNDKNAND pricing tracking ahead of expectations, says JPMorgan
JPMorgan said the NAND market is picking up and pricing is tracking ahead of expectations due to restocking momentum. The firm expects NAND market traction heading into 2H driven by new smartphone launches and a recovery in the PC market. Note SanDisk is leveraged to NAND.
06:13 EDTAZNAstraZeneca to invest $285M in new biologics manufacturing facility in Sweden
AstraZeneca announced that it plans to invest approximately $285M in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The new plant will be focused on filling and packaging of protein therapeutics. It is anticipated that the new facility will supply medicines for clinical trial programs of AstraZeneca and MedImmune, the company’s global biologics research and development arm, from the end of 2018, and will deliver finished products for commercial use once fully operational by 2019. Södertälje is currently home to AstraZeneca’s largest global tablets and capsules manufacturing facility and is also a launch platform site for the company, with specialist capabilities on-site that allow large-scale production of new medicines, working closely with the research and development organisation. By locating the new manufacturing plant in Södertälje, the company will combine its expertise in biologics with the well-established culture of operational excellence that exists within the Sweden Operations unit. The planned investment will, subject to relevant approvals by the local authorities, create between 150 and 250 highly skilled new roles at AstraZeneca by 2019. The new manufacturing facility in Sweden will support the progression of drug candidates across the main therapy areas and be aligned with investments being made in the current biologics manufacturing centers, such as the expansion in Frederick, Maryland, announced in November.
May 17, 2015
15:49 EDTAZNAstraZeneca reports Movantik shows 'similar' adverse event rate vs. placebo
Subscribe for More Information
May 15, 2015
11:46 EDTCMGEl Pollo Loco plummets after Q1 comparable restaurant sales growth slows
Subscribe for More Information
10:29 EDTISRGAmerican Urological Association to hold an annual meeting
Subscribe for More Information
09:31 EDTAZNAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
May 14, 2015
09:22 EDTAZNLeerink pharma/biotech analysts hold an analyst/industry conference call
Subscribe for More Information
05:52 EDTAZNMizuho expects CAR T stocks to be volatile after ASCO abstract
Subscribe for More Information
May 13, 2015
17:24 EDTAZNAstraZeneca to update progress with immuno-oncology pipeline at ASCO
AstraZeneca and MedImmune, the company’s global biologics research and development arm, will demonstrate rapid progress with their combination-focused oncology pipeline at the American Society of Clinical Oncology, or ASCO, Annual Meeting, May 29-June 2. 61 scientific abstracts will be presented at the meeting, reinforcing the significant progress in immuno-oncology through combination therapies and innovative companion diagnostics.
15:32 EDTAKAMLimelight Networks says favorable ruling received in Akamai patent suit
Subscribe for More Information
14:10 EDTAKAMCourt says Limelight Networks did not infringe on Akamai patent, Bloomberg says
Subscribe for More Information
10:28 EDTAKAMCourt says Limelight Networks did not infringe on Akamai patent, Bloomberg says
Akamai was looking to reinstate $45.5M patent verdict, added Bloomberg.
10:08 EDTSNDKRumor: SanDisk strength attributed to renewed takeover speculation
Subscribe for More Information
07:32 EDTAKAMCLSA to hold a conference
Subscribe for More Information
May 12, 2015
10:01 EDTISRGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:31 EDTAKAMAkamai management to meet with JMP Securities
Meetings to be held in Denver on May 13 and in Los Angeles on May 14 hosted by JMP Securities.
05:34 EDTISRGIntuitive Surgical initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Matt O'Brien started shares of Intuitive Surgical with a Neutral rating and $505 price target. O'Brien calls the stock "simply too expensive" relative to expected sales and earnings, but admits Intuitive's robotic surgical technology will likely dominate the market in the coming years. Further, the analyst thinks the company's da Vinci Prostatectomy and da Vinci Hysterectomy procedures could contract amid new diagnostic tests and insurance pushback. The stock closed yesterday up $2.05 to $496.37.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use